BrightSpring Announces Pricing of Secondary Offering of Common Stock
Globenewswire· 2025-06-11 01:59
Core Viewpoint - BrightSpring Health Services, Inc. announced the pricing of a secondary offering of 14,000,000 shares at $21.75 per share, with proceeds going to the selling stockholders, including KKR affiliates and management members [1] Group 1: Offering Details - The offering is underwritten and will close on June 12, 2025, subject to customary closing conditions [1] - The KKR Selling Stockholder has granted underwriters a 30-day option to purchase an additional 2,100,000 shares [1] - No shares are being sold by BrightSpring itself in this offering [1] Group 2: Underwriters and Managers - Goldman Sachs & Co. LLC, BofA Securities, Jefferies, and Morgan Stanley & Co. LLC are the lead book-running managers for the offering [2] - KKR Capital Markets LLC is acting as the lead managing agent [2] - A number of other firms are participating as bookrunners and co-managers for the offering [2] Group 3: Registration and Compliance - A shelf registration statement was filed with the SEC on June 10, 2025, and became effective upon filing [3] - The offering will be made only by means of a prospectus supplement and accompanying prospectus [4]
Grupo Financiero Galicia S.A. Announces Pricing of Secondary Offering of American Depositary Shares by HSBC Bank plc
Globenewswire· 2025-06-11 01:29
Core Viewpoint - Grupo Financiero Galicia S.A. announced a secondary offering of 11,721,449 American Depositary Shares (ADSs) at a price of $54.25 per ADS, representing 117,214,490 Class B ordinary shares, with proceeds going entirely to the selling shareholder, HSBC Bank plc [1][2]. Company Overview - Grupo Financiero Galicia S.A. is one of Argentina's largest financial services groups, focusing on creating long-term value through various financial services including savings, credit, investment, insurance, and digital solutions [6][7]. - The company has over 110 years of experience and operates through multiple subsidiaries, including Banco de Galicia y Buenos Aires S.A.U., Galicia Más Holdings, and Galicia Seguros, among others [7]. Offering Details - The offering is conducted under an effective shelf registration statement filed with the U.S. Securities and Exchange Commission (SEC), and a final prospectus supplement will be available [3]. - The offering is expected to close on June 12, 2025, subject to customary closing conditions [2]. Regulatory Information - The ADSs are not authorized for public offering in Argentina and are not being sold under Argentine Capital Markets Law [1]. - The documents related to the offering have not been reviewed or authorized by the Argentine National Securities Exchange Commission (CNV) [1]. Investor Contact - For further inquiries, the investor relations officer can be contacted via the provided email and phone number [8].
Brookfield Wealth Solutions Announces Results for Election of Directors
Globenewswire· 2025-06-11 01:28
Core Points - Brookfield Wealth Solutions announced the approval of all business items at its annual general and special meeting of shareholders held virtually [1] - All five nominees for the board of directors from both class A and class B shares were elected [2] Election Results - Class A shareholders voted as follows for the five nominated directors: - Dr. Soonyoung Chang: 23,747,124 votes (99.17% for, 0.83% withheld) - William Cox: 22,970,300 votes (95.92% for, 4.08% withheld) - Michele Coleman Mayes: 23,696,733 votes (98.96% for, 1.04% withheld) - Lars Rodert: 23,273,435 votes (97.19% for, 2.81% withheld) - Anne Schaumburg: 23,678,628 votes (98.88% for, 1.12% withheld) [3] - The holder of class B shares voted all 24,000 shares in favor of the five nominated directors: Barry Blattman, Gregory Morrison, Lori Pearson, Sachin Shah, and Jay Wintrob [3] Additional Approvals - All other matters presented at the meeting were approved by shareholder vote, with a summary of the votes to be available on EDGAR and SEDAR [4] Company Overview - Brookfield Wealth Solutions focuses on securing financial futures through retirement services, wealth protection products, and tailored capital solutions [5]
The North West Company Inc. Announces First Quarter Earnings and a Quarterly Dividend
Globenewswire· 2025-06-11 01:00
Core Viewpoint - The North West Company Inc. reported a strong first quarter performance for 2025, with increased sales and earnings driven by same-store sales growth and operational improvements, while also announcing a quarterly dividend of $0.40 per share [1][2]. Financial Highlights - First quarter consolidated sales rose by 3.9% to $641.4 million from $617.5 million last year, primarily due to same-store sales gains and new store contributions [3]. - Gross profit increased by 7.2% to $214.0 million, attributed to sales gains and a 103 basis point rise in gross profit rate [4]. - Selling, operating, and administrative expenses rose by $13.9 million or 8.7%, largely due to investments in staff and technology for operational excellence initiatives [5]. - Earnings from operations (EBIT) increased by 1.2% to $40.3 million, while EBITDA rose by 3.2% to $70.1 million [6]. - Net earnings increased by 2.2% to $27.7 million, with adjusted net earnings rising by 14.2% to $33.6 million [9]. Operational Insights - The company emphasized the importance of the Next 100 initiative, which focuses on operational excellence and aims to enhance customer satisfaction and shareholder value [2]. - There was a notable improvement in on-shelf availability and merchandise assortment, contributing to the positive sales performance [2]. Tax and Interest Expenses - Interest expense decreased by 10.5% to $3.9 million due to lower interest rates and long-term debt [7]. - Income tax expense increased to $8.7 million, influenced by higher earnings and an increased effective tax rate of 23.9% [8]. Company Profile - The North West Company Inc. operates 229 stores across Canada, Alaska, the South Pacific, and the Caribbean, with annualized sales of approximately CDN$2.6 billion [26].
Global Uranium Corp. Announces LIFE Offering for up to C$1,500,000
Globenewswire· 2025-06-11 00:43
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, June 10, 2025 (GLOBE NEWSWIRE) -- Global Uranium Corp. (CSE: GURN | FRA: Q3J) (the “Company”) is pleased to announce that it intends to complete a non-brokered private placement financing (the “Offering”) of a minimum of 1,666,666 units of the Company (each, a “Unit”) and a maximum of 10,000,000 Units, at a price of C$0.15 per Unit, for gross minimum proceeds of C$250,000 and gross ...
Prime Drink Group Provides an Update on Its Bottling Subsidiary Receivership
Globenewswire· 2025-06-11 00:21
Core Viewpoint - Prime Drink Group Corp.'s bottling subsidiary, Triani Canada Inc., has been placed into receivership, ceasing operations as of June 10, 2025, due to a request from principal creditors [1] Group 1: Company Operations - The parent company, Prime Drink Group Corp., and its other subsidiaries are not affected by the receivership of Triani, and operations continue [2] - Prime is evaluating options to acquire certain strategic assets of Triani and is considering other avenues regarding Triani and its stakeholders [3] Group 2: Management and Strategy - The company aims to recover what is owed and continue developing its strategic water and beverage assets, emphasizing its commitment to innovation and brand strategy [4] - Jean Gosselin has been appointed as Chief Financial Officer, bringing over 40 years of experience in finance and operations [5] Group 3: Industry Commitment - Prime reaffirms its commitment to the responsible development of water resources in Québec, with positive discussions ongoing with government authorities [5] Group 4: Company Overview - Prime Drink Group Corp. is a Québec-based corporation focused on becoming a leading diversified holding company in the beverage, influencer media, and hospitality sectors [6]
Quest PharmaTech Announces Opposition to OQPBIOM's Acquisition of AdBioTech
Globenewswire· 2025-06-10 23:14
EDMONTON, Alberta, June 10, 2025 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V: QPT) (“Quest” or the “Company”), a Canadian based pharmaceutical company developing products to improve the quality of life through investee companies and proprietary technologies, announced today that Quest was not informed or consulted, opposes and will not support the recently announced acquisition by privately held South Korea-based OQPBIOM Inc. (“OQM”) of a controlling interest in AdBioTech Co., Ltd. (“AdBioTech”), a pub ...
Perseus Mining Announces 5 Year Gold Production Outlook
Globenewswire· 2025-06-10 22:40
Perth, June 11, 2025 (GLOBE NEWSWIRE) -- Perth, Western Australia/ June 11, 2025/ Perseus Mining Limited (ASX/TSX: PRU) (Company) is pleased to provide its gold production and All-In Site Cost (AISC) outlook for the five-year period from FY26 to FY30 inclusive for its portfolio of mines located in Ghana, Côte d’Ivoire and Tanzania. The Five-year Operating Outlook incorporates the updated planning outlook for each of Perseus’s three existing operations based on planning assumptions reflecting current operat ...
Aja Health and Wellness Inc. Provides Update on Delay in Filing Financial Statements
Globenewswire· 2025-06-10 22:10
Core Viewpoint - Aja Health and Wellness Inc. is nearing the completion of its annual audited financial statements for the year ending December 31, 2024, following a delay caused by the need for a valuation related to a reverse takeover transaction [2][3]. Group 1: Financial Filing Updates - The Alberta Securities Commission issued a management cease trade order (MCTO) on May 6, 2025, due to Aja's inability to file the Required Annual Filings by the April 30, 2025 deadline [2][4]. - Aja has retained a valuator to complete the necessary valuation for the financial statements, which is expected to be completed by July 4, 2025, with the Required Annual Filings anticipated to be submitted by July 31, 2025 [3]. - The MCTO will remain in effect until two full business days after the Required Annual Filings are filed, restricting trading by executive officers but allowing regular trading by other investors [4]. Group 2: Interim Financial Statements - Due to the delay in filing the Required Annual Filings, Aja was also unable to file its unaudited interim financial statements for the three months ended March 31, 2025, by the May 30, 2025 deadline [6]. - Aja is working to complete the Interim Filings and expects to file them concurrently with the Required Annual Filings [6].
argenx Presents New Efgartigimod Data at EULAR 2025 Highlighting Positive Phase 2 Proof-of-Concept Results in Myositis and Sjogren’s Disease
Globenewswire· 2025-06-10 22:01
ALKIVIA data demonstrate significant improvement in muscle strength and physical function in myositis patients treated with efgartigimodRHO data show efgartigimod achieved sustained reduction in autoantibodies and improved functional outcomes in patients with Sjogren’s disease; program granted U.S. FDA Fast Track designationargenx committed to new therapeutic areas in rheumatology with ongoing Phase 3 studies in myositis (ALKIVIA) and Sjogren’s disease (UNITY) June 11, 2025, 12:01 AM CET Amsterdam, the Net ...